ITN Contributing Editor Greg Freiherr interviews Kim Garriott, Principal Consultant, Logicalis
The rapidly expanding volume of unstructured data, exemplified by medical images, underscores the need to develop an enterprise imaging strategy, says Kim Garriott, principal consultant at Logicalis, a global provider of IT solutions and managed services.
In the accompanying video interview, Garriott explains how the combination of these two may form a convincing argument for the leadership of your organization to move forward with enterprise imaging.
On June 1, at the upcoming SIIM 2018 convention, she will co-host the continuing education session “Achieving Enterprise Imaging Maturity,” during which she and the HIMSS-SIIM Workgroup will present the new Digital Imaging Adoption Maturity Model. DIAM, as it is called, is designed to support real-time collaboration and patient-centric care by providing a method to address enterprise-wide imaging challenges.
When developing an enterprise imaging strategy, organizations must consider their specific needs, which are characterized in “use cases.” Garriott, who is the global chair of the HIMSS analytic DIAM Development team and co-chair of the HIMSS-SIIM Enterprise Imaging Workgroup, explains that these use cases constitute one very important element of the enterprise imaging strategy. Another is construction of a “data governance model.” This model is needed to guide the capture of data and is essential to the success of enterprise imaging.
Editor’s Note: This pre-SIIM video interview is the first in a series of three by ITN Contributing Editor, Greg Freiherr. The series features industry luminaries discussing key issues associated with the upcoming SIIM conference.
Related Video: ITN Associate Editor Jeff Zagoudis discusses, "Enterprise Imaging and the Digital Imaging Adoption Model" with Kim Garriott at HIMSS 2018.
5 ViewsRecent Videos View all 660 items
This summer, the Philips Radiology Experience Tour has been bringing Philips imaging modalities directly to the professionals that use them.
This tour offers physicians, technologists and administrators a unique opportunity to see equipment demonstrations and virtual simulations up close and in person!
Imaging Technology News spoke with Flavia Parisi and Tammie Rupnik to learn more about the Philips Radiology Experience Tour and how Philips continues to drive innovation.
If you weren't able to make it to any of the 2023 tour stops, stay tuned because the Tour will return in 2024!
Related Content:
Take a Test Drive on the Philips Radiology Experience Tour
BLOG: Artificial Intelligence Provides Radiologists with Solutions for Today … and Tomorrow
VIDEO: Talking Trends with Philips: Connecting Data and Technology
Philips Advances AI-powered Diagnostic Systems and Transformative Workflow Solutions at RSNA 2022
Fujifilm recently expanded its enterprise imaging portfolio with Synapse Pathology, the company’s newly acquired and branded digital pathology PACS solution.
Synapse Pathology is an open, vendor-agnostic, end-to-end solution designed for medical facilities that handle large volumes of pathology images and data across multiple locations.
Imaging Technology News recently met with Fujifilm’s Bill Lacy and Mark Lloyd, and Chuck Barkey at West Virginia University Medicine to learn more about this new addition to the Synapse Enterprise Imaging portfolio.
Related content:
Rural Hospital Raises the Bar with Comprehensive State-of-the-art Imaging Systems
Fujifilm’s Synapse Pathology Wins 2023 MedTech Breakthrough Award
Develop, Partner, Acquire or Avoid: Where is Investment for Digital Pathology Headed?
Bayer Calantic and Blackford Analysis have teamed up with new artificial intelligence (AI) innovations to address the radiology challenges of today and tomorrow.
Imaging Technology News recently spoke with Thanos Karras, Head of Bayer Digital Solutions Business Americas, and Ben Panter, Founder and CEO of Blackford Analysis, to learn more about this new relationship and their strategy to drive radiology advancements with artificial intelligence.
Related Bayer Artificial Intelligence Content:
Bayer Offers The Complete Guide to Artificial Intelligence in Radiology, a Free eBook
Bayer Announces Acquisition of Blackford Analysis to Advance AI in Radiology Imaging
Talking Trends with Bayer: Transforming Radiology with Digital Solutions
HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. ITN spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Using Maturity Models to Measure Digital Health
Cybersecurity: How Healthcare is at Risk
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
C-COMM: HIMSS New Non-Acute Care Digital Maturity Model
HIMSS Leadership Pinpoints Priority Issues for 2023 Global Conference
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New Non-Acute Care Roadmap: HIMSS Digital Maturity Model Strategy
Sponsored Videos View all 177 items
This summer, the Philips Radiology Experience Tour has been bringing Philips imaging modalities directly to the professionals that use them.
This tour offers physicians, technologists and administrators a unique opportunity to see equipment demonstrations and virtual simulations up close and in person!
Imaging Technology News spoke with Flavia Parisi and Tammie Rupnik to learn more about the Philips Radiology Experience Tour and how Philips continues to drive innovation.
If you weren't able to make it to any of the 2023 tour stops, stay tuned because the Tour will return in 2024!
Related Content:
Take a Test Drive on the Philips Radiology Experience Tour
BLOG: Artificial Intelligence Provides Radiologists with Solutions for Today … and Tomorrow
VIDEO: Talking Trends with Philips: Connecting Data and Technology
Philips Advances AI-powered Diagnostic Systems and Transformative Workflow Solutions at RSNA 2022
Philips Radiology Operations Command Center (ROCC) is a vendor-neutral, multi-modality, multi-site telepresence tool that provides advanced tele-acquisition capabilities and connects imaging experts at a Command Center with technologists at scanning locations across an organization.
Imaging Technology News recently met with Tanuj Gupta, Business Category Leader, Operational Informatics, and Omkar Phanse, Market Leader, Radiology Workflow Solutions, to learn more about this powerful tele-presence tool.
Find more RSNA22 coverage here
Philips Advances AI-powered Diagnostic Systems and Transformative Workflow Solutions at RSNA 2022
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research, development, and manufacture of a new contrast agent.
Imaging Technology News talked to Jeff Fleming, president and CEO, at RSNA 2022 to learn more about this relationship and find out what Bracco is doing for the future of radiology.
For more information: www.vueway.com
Find more RSNA22 coverage here
Related content:
Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent
First Nationwide Use of Bracco's VUEWAY (gadopiclenol) Solution for Injection for MRI
Guerbet Announces Commercial Launch and First Patient Dosing of Elucirem (Gadopiclenol) Injection
Agfa continues develop new products and technologies in its premium and value direct radiography segments including the Valory digital radiography room and the DR 100S.
Imaging Technology News stopped by the Agfa booth at RSNA 2022 to learn more about these products as well as the company’s technology roadmap for the future.
Find more RSNA22 coverage here
Technology Reports View all 12 items
This is an overview of trends and technologies in radiology artificial intelligence (AI) applications in 2021. Views were shared by 11 radiologists using AI and industry leaders, which include:
• Randy Hicks, M.D., MBA, radiologist and CEO of Reginal Medical Imaging (RMI), and an iCAD Profound AI user.
• Prof. Dr. Thomas Frauenfelder, University of Zurich, Institute for Diagnostic and Interventional Radiology, and Riverain AI user.
• Amy Patel, M.D., medical director of Liberty Hospital Women’s Imaging, assistant professor of radiology at UMKC, and user of Kios AI for breast ultrasound.
• Sham Sokka, Ph.D., vice president and head of innovation, precision diagnosis, Philips Healthcare.
• Ivo Dreisser, Siemens Healthineers, global marketing manager for the AI Rad Companion.
• Bill Lacey, vice president of medical informatics, Fujifilm Medical Systems USA.
• Karley Yoder, vice president and general manager, artificial intelligence, GE Healthcare.
• Georges Espada, head of Agfa Healthcare digital and computed radiography business unit.
• Pooja Rao, head of research and development and co-founder of Qure.ai.
• Jill Hamman, world-wide marketing manager at Carestream Health.
• Sebastian Nickel, Siemens Healthineers, global product manager for the AI Pathway Companion.
There has been a change in attitudes about AI on the expo floor at the Radiological Society of North America (RSNA) over the last two years. AI conversations were originally 101 level and discussed how AI technology could be trained to sort photos of dogs and cats. However, in 2020, with numerous FDA approvals for various AI applications, the conversations at RSNA, and industry wide, have shifted to that of accepting the validity of AI. Radiologists now want to discuss how a specific AI algorithm is going to help them save time, make more accurate diagnoses and make them more efficient.
With a higher level of maturity in AI and the technology seeing wider adoption, radiologists using it say AI gives them additional confidence in their diagnoses, and can even help readers who may not be deep experts in the exam type they are being asked to read.
With a myriad of new AI apps gaining regulatory approval from scores of imaging vendors, the biggest challenge for getting this technology into hospitals is an easy to integrate format. This has led to several vendors creating AI app stores. These allow AI apps to integrate easily into radiology workflows because the apps are already integrated as third-party software into a larger radiology vendors' IT platform.
There are now hundreds of AI applications that do a wide variety of analysis, from data analytics, image reconstruction, disease and anatomy identification, automating measurements and advanced visualization. The AI applications can be divided into 2 basic types — AI to improve workflow, and AI for clinical decision support, such as diagnostic aids.
On the workflow side, several vendors are leveraging AI to pull together all of a patients' information, prior exams and reports in one location and to digest the information so it is easier for the radiologist to consume. Often the AI pulls only data and priors that relate to a specific question being asked, based on the imaging protocol used for the exam. One example of this is the Siemens Healthineers AI Clinical Pathway and Siemens AI integrations with PACS to automate measurements and advanced visualization.
AI is also helping simplify complex tasks and help reduce the reading time on involved exams. One example of this is in 3-D breast tomosythesis with hundreds of images, which is rapidly replacing 2-D mammography, which only produces 4 images. Another example is automated image reconstruction algorithms to significantly reduce manual work. AI also is now being integrated directly into several vendors' imaging systems to speed workflow and improve image quality.
Vendors say AI is here to stay. They explain the future of AI will be automation to help improve image quality, simplify manual processes, improved diagnostic quality, new ways to analyze data, and workflow aids that operate in the background as part of a growing number of software solutions.
Several vendors at RSNA 2020 noted that AI's biggest impact in the coming years will be its ability to augment and speed the workflow for the small number of radiologists compared to the quickly growing elder patient populations worldwide. There also are applications in rural and developing countries were there are very low numbers of physicians or specialists.
Related AI in Medical Imaging Content:
AI Outperforms Humans in Creating Cancer Treatments, But Do Doctors Trust It?
VIDEO: Artificial Intelligence For MRI Helps Overcome Backlog of Exams Due to COVID
How AI is Helping the Fight Against Breast Cancer
VIDEO: Use of Artificial Intelligence in Nuclear Imaging
3 High-impact AI Market Trends in Radiology at RSNA 2019
Photo Gallery of New Imaging Technologies at RSNA 2019
VIDEO: Editors Choice of the Most Innovative New Radiology Technology at RSNA 2019
Study Reveals New Comprehensive AI Chest X-ray Solution Improves Radiologist Accuracy
VIDEO: Real-world Use of AI to Detect Hemorrhagic Stroke
The Radiology AI Evolution at RSNA 2019
Eliminating Bias from Healthcare AI Critical to Improve Health Equity
VIDEO: FDA Cleared Artificial Intelligence for Immediate Results of Head CT Scans
Building the Future of AI Through Data
Integrating Artificial Intelligence in Treatment Planning
Selecting an AI Marketplace for Radiology: Key Considerations for Healthcare Providers
Artificial Intelligence Improves Accuracy of Breast Ultrasound Diagnoses
Artificial Intelligence Greatly Speeds Radiation Therapy Treatment Planning
WEBINAR: Building the Bridge - How Imaging AI is Delivering Clinical Value Across the Care Continuum
AI in Medical Imaging Market to Reach $1.5B by 2024
VIDEO: AI-Assisted Automatic Ejection Fraction for Point-of-Care Ultrasound
5 Trends in Enterprise Imaging and PACS Systems
VIDEO: Artificial Intelligence to Automate CT Calcium Scoring and Radiomics
Scale AI in Imaging Now for the Post-COVID Era
VIDEO: Integrating Artificial Intelligence Into Radiologists Workflow
Northwestern Medicine Introduces Artificial Intelligence to Improve Ultrasound Imaging
Find more artificial intelligence news and video
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence (AI) advances at the Radiological Society of North America (RSNA) 2019 annual meeting.
In Enterprise Imaging at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of enterprise imaging advances at the Radiological Society of North America (RSNA) 2019 annual meeting.
In Artificial Intelligence 2018: What Radiologists Need to Know About AI, ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence (AI) advances at the Radiological Society of North America (RSNA) 2018 annual meeting.
Related Artificial Intelligence Content
Technology Report: Artificial Intelligence 2017
VIDEO: RSNA Post-game Report on Artificial Intelligence
VIDEO: AI in Tumor Diagnostics, Treatment and Follow-up
VIDEO: Artificial Intelligence May Help Reduce Gadolinium Dose in MRI
Radiation Oncology View all 137 items
Dr. Frank A. Vicini, MD, FACR, FASTRO, FABS, who is a radiation oncologist with GenesisCare, discussed his findings from a phase III trial presented at ASTRO22 that evaluated new and improved techniques to treat patients with breast cancer. Here he shares some of his findings with Imaging Technology News (ITN).
Related Conference Coverage:
Photo Gallery of Technologies Showcased at ASTRO 2022
ASTRO 2022 Shines Spotlight on “Cancer Breakthroughs” with AAPM, ASCO Research
“Cancer Breakthroughs” Session at ASTRO2022 Unveils Key Findings from ASCO, AAPM
Looking Ahead to ASTRO: Keynotes, Awards and Scientific Session Updates
John C. Breneman, M.D., medical director of the Cincinnati Children's/UC Health Proton Therapy Center, and the principal investigator of the FAST-01 trial, explains FLASH therapy and details on the trial. This study is testing the use of a single FLASH proton therapy session, rather than weeks of fractionated doses.
FLASH and hypo fractionated therapy have been among the hottest topics in radiation oncology. The premise of FLASH is to deliver extremely high doses of radiation to a tumor in one, short dose. Lab testing has shown this actually has a healthy tissue sparing capability and may help in reducing collateral damage.
If this and other trials show benefit and improved outcomes from FLASH, it is possible this may become the primary treatment method for many cancers in the years to come. Reducing therapy to one treatment session also would open up much more time for proton centers so many more patients could be treated. It also would be a significant time and cost savings for patients and their families, who would not be required to stay at nearby hotels for extended stays during their course of treatment.
Cincinnati Children's/UC Health Proton Therapy Center announced the completion of enrollment in FAST-01 (FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases) in October. This is the first human clinical trial of FLASH therapy, which centered on patients with metastases in arms and legs to avoid irradiating critical structures. If this trials shows benefits and low toxicity, followup studies will attempt more complex treatments in other parts of the body.
Related ASTRO 2021 Radiation Oncology Content:
7 Trends in Radiation Therapy at ASTRO 2021
Radiation Oncology Research Featured at ASTRO 2021
Photo Gallery of Technologies at ASTRO 2021
VIDEO: Sedating Children With Movies Rather Than Drugs for Radiation Therapy — Interview with Jeffrey T. Chapman
VIDEO: 4 Radiation Oncology Technologies to Watch — Interview with Anthony Zietman, M.D.
VIDEO: Advances in Radiopharmaceutical Therapy — Interview with Ana Kiess, M.D., Ph.D.
VIDEO: MRI-Linac and PSMA PET Imaging Technologies Aids Therapy at GenesisCare — Interview with Walter Curran, Jr. M.D.,
VIDEO: Elekta Harmony Radiotherapy System Walk-around
VIDEO Example of the Varian Noona Bidirection Oncology Patient Interface Software
VIDEO: Examples of Cherenkov Radiation Imaging During Radiation Therapy
Elekta’s latest linear accelerator, Harmony, is designed to provide a productive and versatile radiotherapy solution for both mature and developing markets. ITN recently spoke with Chris Gilpin, Global Product Marketing Manager, and Emily Basset, Global Clinical Marketing Manager, to learn more about the treatment system.
Related content:
Growing Use of Nuclear Medicine and Radiation Therapy for Diagnosis and Treatment
7 Trends in Radiation Therapy at ASTRO 2021
VIDEO: Elekta Harmony Radiotherapy System Walk-around
Photo Gallery of Technologies at ASTRO 2021
Magdalena Bazalova-Carter, Ph.D., assistant professor, University of Victoria University, discusses the current state of ultra-high dose FLASH radiation therapy at the 2021 American Society of Radiation Oncology (ASTRO) annual meeting. Flash therapy is said to be a key technology to keep an eye on in the next few years. If it proves viable in human patients, it promises to greatly shorten treatment times, and reduce fractions to between 1-3 sessions.
The idea is that a super-high dose of radiation is delivered in one large, very fast dose. It appears that despite the high dose of radiation, there is a tissue sparing biology mechanism that is not yet fully understood, where health tissue is preserved and there is less collateral damage than the standard series of lower dose fractions over days or weeks.
Flash therapy is being tested in electron beam therapy systems to treat superficial cancers, which are much easier to adopt to flash than deeper tissue tumors. Proton may be able to produce the higher energies needed for deeper tumor treatments, but current photon beam systems are limited because to deliver the high doses needed may cause enough heat to melt the X-ray beam source.
7 Trends in Radiation Therapy at ASTRO 2021
Photo Gallery of Technologies at ASTRO 2021
Radiology Imaging View all 396 items
This summer, the Philips Radiology Experience Tour has been bringing Philips imaging modalities directly to the professionals that use them.
This tour offers physicians, technologists and administrators a unique opportunity to see equipment demonstrations and virtual simulations up close and in person!
Imaging Technology News spoke with Flavia Parisi and Tammie Rupnik to learn more about the Philips Radiology Experience Tour and how Philips continues to drive innovation.
If you weren't able to make it to any of the 2023 tour stops, stay tuned because the Tour will return in 2024!
Related Content:
Take a Test Drive on the Philips Radiology Experience Tour
BLOG: Artificial Intelligence Provides Radiologists with Solutions for Today … and Tomorrow
VIDEO: Talking Trends with Philips: Connecting Data and Technology
Philips Advances AI-powered Diagnostic Systems and Transformative Workflow Solutions at RSNA 2022
Bayer Calantic and Blackford Analysis have teamed up with new artificial intelligence (AI) innovations to address the radiology challenges of today and tomorrow.
Imaging Technology News recently spoke with Thanos Karras, Head of Bayer Digital Solutions Business Americas, and Ben Panter, Founder and CEO of Blackford Analysis, to learn more about this new relationship and their strategy to drive radiology advancements with artificial intelligence.
Related Bayer Artificial Intelligence Content:
Bayer Offers The Complete Guide to Artificial Intelligence in Radiology, a Free eBook
Bayer Announces Acquisition of Blackford Analysis to Advance AI in Radiology Imaging
Talking Trends with Bayer: Transforming Radiology with Digital Solutions
In addition to women with dense breasts, there are also other women for whom mammographic screening is not really enough, which is why research needs to continue in this field. Dr. Wendie Berg, a leading breast cancer specialist, talks with ITN about new research and advancements in breast imaging technology.
Dr. Berg, MD, PhD, FACR, FSBI, is Professor of Radiology at the University of Pittsburgh School of Medicine and Magee-Womens Hospital of UPMC, specializing in breast imaging. She is also the Chief Scientific Advisor to DenseBreast-info.org. A renowned expert, she writes and co-edits one of the leading textbooks on the topic, Diagnostic Imaging: Breast, currently in its third edition, and has co-authored over 120 peer-reviewed research publications.
Related Breast Density Content:
VIDEO: FDA Update on the US National Density Reporting Standard - A Discussion on the Final Rule
One on One … with Wendie Berg, MD, PhD, FACR, FSBI
Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer
Creating Patient Equity: A Breast Density Legislative Update
AI Provides Accurate Breast Density Classification
VIDEO: The Impact of Breast Density Technology and Legislation
VIDEO: Personalized Breast Screening and Breast Density
VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference
Fake News: Having Dense Breast Tissue is No Big Deal
The Manic World of Social Media and Breast Cancer: Gratitude and Grief
Related Breast Imaging Content:
Single vs. Multiple Architectural Distortion on Digital Breast Tomosynthesis
Today's Mammography Advancements
Digital Breast Tomosynthesis Spot Compression Clarifies Ambiguous Findings
AI DBT Impact on Mammography Post-breast Therapy
ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI
Radiologist Fatigue, Experience Affect Breast Imaging Call Backs
Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography
Study Finds Racial Disparities in Access to New Mammography Technology
It has long been said that a national reporting standard is needed in order to ensure all American women receive at least the same basic information regarding breast density, and a spotlight put on the importance of routine breast imaging. Dr. Wendie Berg, a leading breast cancer specialist, shares with ITN what is being done in the fight against breast cancer and the importance of this standardization in reporting for women.
Dr. Berg, MD, PhD, FACR, FSBI, is Professor of Radiology at the University of Pittsburgh School of Medicine and Magee-Womens Hospital of UPMC, specializing in breast imaging. She is also the Chief Scientific Advisor to DenseBreast-info.org. A renowned expert, she writes and co-edits one of the leading textbooks on the topic, Diagnostic Imaging: Breast, currently in its third edition, and has co-authored over 120 peer-reviewed research publications.
Related Breast Density Content:
VIDEO: Research and Advancements in Breast Imaging Technology
One on One … with Wendie Berg, MD, PhD, FACR, FSBI
Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer
Creating Patient Equity: A Breast Density Legislative Update
AI Provides Accurate Breast Density Classification
VIDEO: The Impact of Breast Density Technology and Legislation
VIDEO: Personalized Breast Screening and Breast Density
VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference
Fake News: Having Dense Breast Tissue is No Big Deal
The Manic World of Social Media and Breast Cancer: Gratitude and Grief
Related Breast Imaging Content:
Single vs. Multiple Architectural Distortion on Digital Breast Tomosynthesis
Today's Mammography Advancements
Digital Breast Tomosynthesis Spot Compression Clarifies Ambiguous Findings
AI DBT Impact on Mammography Post-breast Therapy
ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI
Radiologist Fatigue, Experience Affect Breast Imaging Call Backs
Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography
Study Finds Racial Disparities in Access to New Mammography Technology
Molecular Imaging View all 34 items
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research, development, and manufacture of a new contrast agent.
Imaging Technology News talked to Jeff Fleming, president and CEO, at RSNA 2022 to learn more about this relationship and find out what Bracco is doing for the future of radiology.
For more information: www.vueway.com
Find more RSNA22 coverage here
Related content:
Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent
First Nationwide Use of Bracco's VUEWAY (gadopiclenol) Solution for Injection for MRI
Guerbet Announces Commercial Launch and First Patient Dosing of Elucirem (Gadopiclenol) Injection
At RSNA 2021, Philips highlighted the launch of two new innovative CT systems – the multi-energy Spectral CT 7500 and the CT 5100 Incisive with embedded AI capabilities. ITN spoke with Wendy Winkle Lawless, CT Business Market Leader - North America, Philips, to learn more about these new systems.
Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins University, explains the current state of patient-centered radiopharmaceutical therapy at the American Society of Radiation Oncology (ASTRO) 2021 meeting.
She discusses development and use over the past decade of Radium-223 dichloride and Lutetium-177 dotatate. Kiess also expects there will be targeted injectable radiopharmaceuticals for nearly all solid tumor types in the next decade. She said her center is currently investigating the use of radiopharma agents to treat oligometastatic metastatic cancers.
Photo Gallery of Technologies at ASTRO 2021
Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are helping advance radiation oncology care during the American Society of Radiation Oncology (ASTRO) 2021 meeting. These technology advances include:
• Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging for prostate cancer.
• MRI-linear accelerator (Linac) systems that allow real-time imaging during radiation therapy.
• Remote treatment planning to help radiation treatment centers that are in rural areas.
Prostate cancer is one of the most common cancers in men. The new PSMA PET imaging is expected to significantly improve how prostate cancer is detected and treated. The FDA approved the drug for PET nuclear imaging of PSMA-positive lesions in men with prostate cancer. 68Ga-PSMA-11 is a radioactive imaging agent that binds to prostate cancer cells to help localize prostate cancer cells.
Photo Gallery of Technologies at ASTRO 2021
Conference Coverage View all 531 items
Fujifilm recently expanded its enterprise imaging portfolio with Synapse Pathology, the company’s newly acquired and branded digital pathology PACS solution.
Synapse Pathology is an open, vendor-agnostic, end-to-end solution designed for medical facilities that handle large volumes of pathology images and data across multiple locations.
Imaging Technology News recently met with Fujifilm’s Bill Lacy and Mark Lloyd, and Chuck Barkey at West Virginia University Medicine to learn more about this new addition to the Synapse Enterprise Imaging portfolio.
Related content:
Rural Hospital Raises the Bar with Comprehensive State-of-the-art Imaging Systems
Fujifilm’s Synapse Pathology Wins 2023 MedTech Breakthrough Award
Develop, Partner, Acquire or Avoid: Where is Investment for Digital Pathology Headed?
Bayer Calantic and Blackford Analysis have teamed up with new artificial intelligence (AI) innovations to address the radiology challenges of today and tomorrow.
Imaging Technology News recently spoke with Thanos Karras, Head of Bayer Digital Solutions Business Americas, and Ben Panter, Founder and CEO of Blackford Analysis, to learn more about this new relationship and their strategy to drive radiology advancements with artificial intelligence.
Related Bayer Artificial Intelligence Content:
Bayer Offers The Complete Guide to Artificial Intelligence in Radiology, a Free eBook
Bayer Announces Acquisition of Blackford Analysis to Advance AI in Radiology Imaging
Talking Trends with Bayer: Transforming Radiology with Digital Solutions
HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. ITN spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Using Maturity Models to Measure Digital Health
Cybersecurity: How Healthcare is at Risk
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
C-COMM: HIMSS New Non-Acute Care Digital Maturity Model
HIMSS Leadership Pinpoints Priority Issues for 2023 Global Conference
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New Non-Acute Care Roadmap: HIMSS Digital Maturity Model Strategy
Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. ITN spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Using Maturity Models to Measure Digital Health
Cybersecurity: How Healthcare is at Risk
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
C-COMM: HIMSS New Non-Acute Care Digital Maturity Model
HIMSS Leadership Pinpoints Priority Issues for 2023 Global Conference
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New Non-Acute Care Roadmap: HIMSS Digital Maturity Model Strategy
Information Technology View all 294 items
This summer, the Philips Radiology Experience Tour has been bringing Philips imaging modalities directly to the professionals that use them.
This tour offers physicians, technologists and administrators a unique opportunity to see equipment demonstrations and virtual simulations up close and in person!
Imaging Technology News spoke with Flavia Parisi and Tammie Rupnik to learn more about the Philips Radiology Experience Tour and how Philips continues to drive innovation.
If you weren't able to make it to any of the 2023 tour stops, stay tuned because the Tour will return in 2024!
Related Content:
Take a Test Drive on the Philips Radiology Experience Tour
BLOG: Artificial Intelligence Provides Radiologists with Solutions for Today … and Tomorrow
VIDEO: Talking Trends with Philips: Connecting Data and Technology
Philips Advances AI-powered Diagnostic Systems and Transformative Workflow Solutions at RSNA 2022
Fujifilm recently expanded its enterprise imaging portfolio with Synapse Pathology, the company’s newly acquired and branded digital pathology PACS solution.
Synapse Pathology is an open, vendor-agnostic, end-to-end solution designed for medical facilities that handle large volumes of pathology images and data across multiple locations.
Imaging Technology News recently met with Fujifilm’s Bill Lacy and Mark Lloyd, and Chuck Barkey at West Virginia University Medicine to learn more about this new addition to the Synapse Enterprise Imaging portfolio.
Related content:
Rural Hospital Raises the Bar with Comprehensive State-of-the-art Imaging Systems
Fujifilm’s Synapse Pathology Wins 2023 MedTech Breakthrough Award
Develop, Partner, Acquire or Avoid: Where is Investment for Digital Pathology Headed?
Bayer Calantic and Blackford Analysis have teamed up with new artificial intelligence (AI) innovations to address the radiology challenges of today and tomorrow.
Imaging Technology News recently spoke with Thanos Karras, Head of Bayer Digital Solutions Business Americas, and Ben Panter, Founder and CEO of Blackford Analysis, to learn more about this new relationship and their strategy to drive radiology advancements with artificial intelligence.
Related Bayer Artificial Intelligence Content:
Bayer Offers The Complete Guide to Artificial Intelligence in Radiology, a Free eBook
Bayer Announces Acquisition of Blackford Analysis to Advance AI in Radiology Imaging
Talking Trends with Bayer: Transforming Radiology with Digital Solutions
HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. ITN spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Using Maturity Models to Measure Digital Health
Cybersecurity: How Healthcare is at Risk
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
C-COMM: HIMSS New Non-Acute Care Digital Maturity Model
HIMSS Leadership Pinpoints Priority Issues for 2023 Global Conference
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New Non-Acute Care Roadmap: HIMSS Digital Maturity Model Strategy
Women's Health View all 81 items
In addition to women with dense breasts, there are also other women for whom mammographic screening is not really enough, which is why research needs to continue in this field. Dr. Wendie Berg, a leading breast cancer specialist, talks with ITN about new research and advancements in breast imaging technology.
Dr. Berg, MD, PhD, FACR, FSBI, is Professor of Radiology at the University of Pittsburgh School of Medicine and Magee-Womens Hospital of UPMC, specializing in breast imaging. She is also the Chief Scientific Advisor to DenseBreast-info.org. A renowned expert, she writes and co-edits one of the leading textbooks on the topic, Diagnostic Imaging: Breast, currently in its third edition, and has co-authored over 120 peer-reviewed research publications.
Related Breast Density Content:
VIDEO: FDA Update on the US National Density Reporting Standard - A Discussion on the Final Rule
One on One … with Wendie Berg, MD, PhD, FACR, FSBI
Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer
Creating Patient Equity: A Breast Density Legislative Update
AI Provides Accurate Breast Density Classification
VIDEO: The Impact of Breast Density Technology and Legislation
VIDEO: Personalized Breast Screening and Breast Density
VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference
Fake News: Having Dense Breast Tissue is No Big Deal
The Manic World of Social Media and Breast Cancer: Gratitude and Grief
Related Breast Imaging Content:
Single vs. Multiple Architectural Distortion on Digital Breast Tomosynthesis
Today's Mammography Advancements
Digital Breast Tomosynthesis Spot Compression Clarifies Ambiguous Findings
AI DBT Impact on Mammography Post-breast Therapy
ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI
Radiologist Fatigue, Experience Affect Breast Imaging Call Backs
Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography
Study Finds Racial Disparities in Access to New Mammography Technology
It has long been said that a national reporting standard is needed in order to ensure all American women receive at least the same basic information regarding breast density, and a spotlight put on the importance of routine breast imaging. Dr. Wendie Berg, a leading breast cancer specialist, shares with ITN what is being done in the fight against breast cancer and the importance of this standardization in reporting for women.
Dr. Berg, MD, PhD, FACR, FSBI, is Professor of Radiology at the University of Pittsburgh School of Medicine and Magee-Womens Hospital of UPMC, specializing in breast imaging. She is also the Chief Scientific Advisor to DenseBreast-info.org. A renowned expert, she writes and co-edits one of the leading textbooks on the topic, Diagnostic Imaging: Breast, currently in its third edition, and has co-authored over 120 peer-reviewed research publications.
Related Breast Density Content:
VIDEO: Research and Advancements in Breast Imaging Technology
One on One … with Wendie Berg, MD, PhD, FACR, FSBI
Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer
Creating Patient Equity: A Breast Density Legislative Update
AI Provides Accurate Breast Density Classification
VIDEO: The Impact of Breast Density Technology and Legislation
VIDEO: Personalized Breast Screening and Breast Density
VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference
Fake News: Having Dense Breast Tissue is No Big Deal
The Manic World of Social Media and Breast Cancer: Gratitude and Grief
Related Breast Imaging Content:
Single vs. Multiple Architectural Distortion on Digital Breast Tomosynthesis
Today's Mammography Advancements
Digital Breast Tomosynthesis Spot Compression Clarifies Ambiguous Findings
AI DBT Impact on Mammography Post-breast Therapy
ImageCare Centers Unveils PINK Better Mammo Service Featuring Profound AI
Radiologist Fatigue, Experience Affect Breast Imaging Call Backs
Fewer Breast Cancer Cases Between Screening Rounds with 3-D Mammography
Study Finds Racial Disparities in Access to New Mammography Technology
Dr. Frank A. Vicini, MD, FACR, FASTRO, FABS, who is a radiation oncologist with GenesisCare, discussed his findings from a phase III trial presented at ASTRO22 that evaluated new and improved techniques to treat patients with breast cancer. Here he shares some of his findings with Imaging Technology News (ITN).
Related Conference Coverage:
Photo Gallery of Technologies Showcased at ASTRO 2022
ASTRO 2022 Shines Spotlight on “Cancer Breakthroughs” with AAPM, ASCO Research
“Cancer Breakthroughs” Session at ASTRO2022 Unveils Key Findings from ASCO, AAPM
Looking Ahead to ASTRO: Keynotes, Awards and Scientific Session Updates
Stamatia Destounis, M.D., FACR, chief of the American College of Radiology (ACR) Breast Commission, managing partner, Elizabeth Wende Breast Care, Rochester, N.Y., explains some of the key trends in breast imaging at the 2021 Radiological Society of North America (RSNA) meeting.
She discusses the trends of 3D mammography seeing rapid growth, adoption of synthetic 2D breast images from the tomosynthesis datasets, contrast-enhanced mammography, and breast MRI to help women with dense breast tissue. Destounis also discusses the use of artificial intelligence (AI) to help radiologists with finding what they needs with larger datasets in 3D mammography, and to help act as a second set of eyes.
Early in 2021, with the roll out of the COVID vaccines, one of the biggest headlines in radiology was that the vaccine can show false positives for cancer because it may cause inflammation of lymph nodes. Destounis explains this issue and how women's health centers have largely overcome this by asking patients about their vaccination status and planning imaging around the vaccination dates.
Related Breast Imaging Content:
COVID-19 Vaccine Can Cause False Positive Cancer Diagnosis
Help Spread Awareness of Potential COVID-19 Vaccine Imaging Side-effects
VIDEO: COVID Vaccine May Cause Enlarged Lymph Nodes on Mammograms — Interview with Constance "Connie" Lehman, M.D.
COVID-19 Vaccination Axillary Adenopathy Detected During Breast Imaging
VIDEO: COVID Vaccine Adenopathy Can Last Up to 10 Weeks — Interview with Yael Eshet, M.D.
VIDEO: Artificial Intelligence Trends in Medical Imaging — Interview with Signify Research
Technology Report: Artificial Intelligence in Radiology 2021